{
    "nctId": "NCT00653718",
    "briefTitle": "Musculoskeletal Pain in Postmenopausal, Early Breast Cancer Patients Receiving Aromatase Inhibitor Therapy - A Pilot Study",
    "officialTitle": "Musculoskeletal Pain in Postmenopausal, Early Breast Cancer Patients Receiving Aromatase Inhibitor Therapy - A Pilot Study",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 30,
    "primaryOutcomeMeasure": "Musculoskeletal pain",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Female\n* Invasive carcinoma of the breast confirmed by needle biopsy or final pathological evaluation of the surgical specimen\n* Breast cancer Stage I, II or IIIa\n* ER and/or PR+\n* No evidence of metastatic disease\n* Post-menopausal\n* May or may not have received adjuvant or neoadjuvant chemotherapy\n* Bilateral infiltrating carcinoma are eligible\n\nExclusion Criteria:\n\n* Men not eligible\n* Other malignancies\n* Patients who have received neoadjuvant or adjuvant endocrine therapy with tamoxifen or an aromatase inhibitor\n* Ongoing treatment with any sex hormonal therapy (these patients are eligible if this therapy is discontinued prior to entry)\n* Therapy with hormonal agent such as raloxifene for osteoporosis\n* Patients receiving glucocorticoids\n* Psychiatric or addictive disorders\n* Inability to read English or French",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}